Skip to main content

Table 1 Epidemiological findings of the study groups

From: Outcomes in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention or pharmacoinvasive strategy in a Latin American country

Characteristic PIs group
n (%)
PPCI group
n (%)
p
Age (in years) (median, IQR) 62 (52–70) 68 (59–75) < 0.001
Male sex 84 (87.5) 70 (92.1) 0.453
Clinical Characteristics    
 Hypertension 42 (43.7) 37 (48.7) 0.519
 Type 2 diabetes mellitus 26 (27.1) 14 (18.4) 0.182
 Dyslipidemia 42 (43.8) 39 (48.6) 0.519
 Smoking habit 21 (21.9) 28 (36.8) 0.031
 Chronic coronary syndrome 4 (4.2) 3 (3.9) 1.000
 Cerebrovascular disease 6 (6.3) 2 (2.6) 0.469
 Previous myocardial infarction 4 (4.2) 3 (3.9) 0.942
 Coronary revascularization 2 (2.1) 3 (3.9) 0.656
 Chronic kidney disease 5 (5.2) 5 (6.6) 0.751
 Chronic heart failure 0 1 (1.3) 0.442
  1. Categorical values are expressed in frequency and percentage (%)
  2. IQR interquartile range, PIs pharmacoinvasive strategy, PPCI primary percutaneous coronary intervention
  3. P value obtained using Pearson’s chi-square and Wilcoxon rank sum test according to the type of variables